WELL THIS WILL BE A HUGE CHANGE IN THE STANDARD OF CARE Beta-Blocker Interruption or Continuation after Myocardial Infarction | New England Journal of Medicine https://t.co/RAM9tJdHZD
Beta-Blocker Interruption or Continuation after Myocardial Infarction.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Sep 2024 – Nov 2025Where it's discussed
-
X / Twitter141 posts
-
News18 articles
-
Facebook5 posts
-
Blogs4 articles
-
YouTube3 videos
-
Bluesky1 posts
AI synopsis
What people are saying
The discussions frequently mention the study’s outcomes and their clinical significance, such as one user stating, 'Don't. Stop. The beta-blocker. 3% absolute risk difference with discontinuation.' This type of language shows urgency, while others refer to it as a 'huge change in the standard of care,' emphasizing how the research could reshape treatment approaches. The tone of excitement and concern across these posts highlights a collective recognition of the publication’s importance.
Most discussions express support for the findings, with many emphasizing the significance of continuing beta-blocker treatment post-myocardial infarction.
The posts demonstrate high curiosity, reflecting a strong desire to understand the implications of the study on clinical practice.
Several contributors engage deeply by referencing the methodology and outcomes, indicating their investment in the topic.
Many participants highlight the potential for changes in treatment protocols, believing this publication could change standards of care significantly.
Abstract in brief
- The study investigates whether stopping beta-blocker treatment after a heart attack is safe and affects patients' quality of life, given the uncertainty about how long these medications should be taken.
- In a trial with nearly 3700 participants, researchers compared outcomes between patients who stopped beta-blockers and those who continued, focusing on major cardiovascular events and quality of life over a median follow-up of 3 years.
- Results showed that 23.8% of those who stopped the medication experienced serious cardiovascular events compared to 21.1% who continued, indicating stopping the drug did not lead to significant health benefits or quality of life improvements, but did not meet the noninferiority criteria.
Top posts
Most liked on X and BlueskyLet’s celebrate the collapse of our language. “In patients with a history of MI, interruption of long-term beta-blocker treatment was not found to be noninferior to a strategy of beta-blocker continuation.” https://t.co/Nhwfp1vGEI
Original Article: Beta-Blocker Interruption or Continuation after Myocardial Infarction (ABYSS) https://t.co/UdF3kWbFsE Editorial: Routine Beta-Blockers in Secondary Prevention — Approaching Retirement? https://t.co/T4PkhhP4Gx #Cardiology https://t.co/kKnrINvYDQ
In the ACTION trial, researchers examined whether interruption of beta-blockers was safe and might improve quality of life in patients with a history of uncomplicated myocardial infarction. Full trial results and Plain Language Summary: https://t.co/UdF3kWbFsE https://t.co/OeyHd8gERa
[NEJM掲載:心筋梗塞後のβ遮断薬] ABYSS試験は心筋梗塞既往に対するβ遮断薬を受けている、EF>40%、6ヶ月以内に心血管イベントがない患者を対象に、β遮断薬中断群と継続群で評価されたものです 心疾患→β遮断薬の漫然とした使用 ではなくなっていきそうです DOI: 10.1056/NEJMoa2404204 https://t.co/l8yVc03Hhf
Their wording is technically accurate, and likely required within the main text of a journal article, given the nuanced study design. It's just not appropriate for a plain language summary. Article: https://t.co/HpblnQFg2q "Plain language summary": https://t.co/ZwF6TOUBSI
All mentions
Advances in Stroke Prevention for Atrial Fibrillation Patients
This video discusses recent research on left atrial appendage closure as a safe and effective alternative to anticoagulation in high-risk atrial fibrillation patients. It highlights reduced bleeding complications and…
Impact of Beta-Blocker Continuation Post-Heart Attack Study Results
This study investigates whether stopping beta-blocker treatment after a heart attack affects patient safety and quality of life. Nearly 3,700 participants were analyzed to compare cardiovascular outcomes over three…
Impact of Beta-Blocker Treatment After Heart Attack
This video discusses the findings of a study on beta-blocker treatment post-myocardial infarction. Researchers explored whether discontinuing beta-blockers affects patient outcomes, revealing no significant health…
RT @NEJM: Original Article: Beta-Blocker Interruption or Continuation after Myocardial Infarction (ABYSS) https://t.co/UdF3kWbFsE Editori…
Gain CPD by watching at: https://t.co/Kb2KYJfalY
RT @KreutzReinhold: Congrats to Dr Silvain, ACTION group for excellent presentation of the ABYSS trial - non-inferiority Probe design at HO…
MI 後のβ遮断薬は、やはり続けた方が良いのかしらね。 PROBEだから言い切れないケドhttps://t.co/CsNRkQqCzY https://t.co/9S4XeQfbaq
RT @chadialraies: Episode 3 from 'Heart of the Matter' ✨, is here, This week we discuss a very interesting paper : "Beta-Blocker Interrup…
Episode 3 from 'Heart of the Matter' ✨, is here, This week we discuss a very interesting paper : "Beta-Blocker Interruption or Continuation after Myocardial Infarction" Watch the episode
Read a summary of "Beta-Blocker Interruption or Continuation after Myocardial Infarction" in the February 2025 Science, Medicine, and the Anesthesiologist: ow.ly/uwT250UH13Y
Read a summary of "Beta-Blocker Interruption or Continuation after Myocardial Infarction" in the February 2025 Science, Medicine, and the Anesthesiologist: https://t.co/xHfqGFIu7h https://t.co/8fh6d1oDLo
RT @drbennisahmed: Top 10 Clinical Trials ACC 2024 Beta-Blocker Interruption or Continuation after Myocardial Infarction interruption of…
RT @drbennisahmed: Top 10 Clinical Trials ACC 2024 Beta-Blocker Interruption or Continuation after Myocardial Infarction interruption of…
RT @drbennisahmed: Top 10 Clinical Trials ACC 2024 Beta-Blocker Interruption or Continuation after Myocardial Infarction interruption of…
Top 10 Clinical Trials ACC 2024 Beta-Blocker Interruption or Continuation after Myocardial Infarction interruption of long-term beta-blocker treatment was not found to be noninferior to a strategy of beta-blocker continuation https://t.co/zIpxhFHc3p
2 min cardiology(臨床、担当:安達歩) Beta-Blocker Interruption or Continuation after Myocardial Infarction J Silvain et al. NEJM 2024; 391: 1277-1286 https://t.co/Tv0VMHkw9T NEJMに2024年8月に掲載された論文。フランスの 49 施設で実施された→
RT @kmd_cardiology: ***Jounal club*** 「Beta-Blocker Interruption or Continuation after Myocardial Infarction」 N Engl J Med 2024;391:1277-1…
https://t.co/hVD4K5foIJ
***Jounal club*** 「Beta-Blocker Interruption or Continuation after Myocardial Infarction」 N Engl J Med 2024;391:1277-1286 心筋梗塞後のβ遮断薬の中断と継続の比較 〜ABYSS trial〜 https://t.co/8XcJF33DFX
ABYSS試験(2024年8月) https://t.co/oaynmnahVQ
Interrupción o continuación de los beta-bloqueantes tras infarto de miocardio https://t.co/YzgYhEKHa9 PMID 39213187
RT @MatthewAllenMD: Beta-Blocker Interruption or Continuation after Myocardial Infarction | New England Journal of Medicine https://t.co/z2…
Beta-Blocker Interruption or Continuation after Myocardial Infarction | New England Journal of Medicine https://t.co/z27FZ1FhZo We need more evidence to guide decisions about the risks and benefits of forgoing or discontinuing treatments - both medical and surgical.
RT @NEJM: In the ACTION trial, researchers examined whether interruption of beta-blockers was safe and might improve quality of life in pat…
RT @NEJM: In the ACTION trial, researchers examined whether interruption of beta-blockers was safe and might improve quality of life in pat…
RT @NEJM: In the ACTION trial, researchers examined whether interruption of beta-blockers was safe and might improve quality of life in pat…
RT @NEJM: In the ACTION trial, researchers examined whether interruption of beta-blockers was safe and might improve quality of life in pat…
RT @NEJM: In the ACTION trial, researchers examined whether interruption of beta-blockers was safe and might improve quality of life in pat…
RT @NEJM: In the ACTION trial, researchers examined whether interruption of beta-blockers was safe and might improve quality of life in pat…
RT @NEJM: In the ACTION trial, researchers examined whether interruption of beta-blockers was safe and might improve quality of life in pat…
RT @NEJM: In the ACTION trial, researchers examined whether interruption of beta-blockers was safe and might improve quality of life in pat…
In the ACTION trial, researchers examined whether interruption of beta-blockers was safe and might improve quality of life in patients with a history of uncomplicated myocardial infarction. Full trial results and Plain Language Summary: https://t.co/UdF3kWbFsE https://t.co/OeyHd8gERa
@jseptic β遮断薬は高血圧に続いてOMI患者でも微妙な雰囲気! ビソプロロール錠は全剤形が1錠10.10円なんだけどなぁ・・ https://t.co/gGYCKWznkE https://t.co/5aqgzAeuVC
@murochan25 β遮断薬はPCI療法以前のエビデンス、 PCI療法後は心不全や死亡が減っており、EFも良いのでβ遮断薬は必要ないってさ ❢ https://t.co/gGYCKWznkE https://t.co/KtZfd1ecJM
Beta-Blocker Interruption or Continuation after Myocardial Infarction Read more here: https://t.co/VZc5hWaE7C #MyocardialInfarction #BetaBlockers #CardiovascularResearch #ClinicalTrial #HeartHealth
RT @drmiguelmarcos: Suspender el beta-bloqueante en pacientes que han tenido un infarto no fue inferior a mantenerlo en este estudio. http…
RT @drmiguelmarcos: Suspender el beta-bloqueante en pacientes que han tenido un infarto no fue inferior a mantenerlo en este estudio. http…
Suspender el beta-bloqueante en pacientes que han tenido un infarto no fue inferior a mantenerlo en este estudio. https://t.co/kQuGYs2RL9
RT @adamcifu: Let’s celebrate the collapse of our language. “In patients with a history of MI, interruption of long-term beta-blocker trea…
RT @adamcifu: Let’s celebrate the collapse of our language. “In patients with a history of MI, interruption of long-term beta-blocker trea…
RT @adamcifu: Let’s celebrate the collapse of our language. “In patients with a history of MI, interruption of long-term beta-blocker trea…
RT @adamcifu: Let’s celebrate the collapse of our language. “In patients with a history of MI, interruption of long-term beta-blocker trea…
RT @adamcifu: Let’s celebrate the collapse of our language. “In patients with a history of MI, interruption of long-term beta-blocker trea…
RT @adamcifu: Let’s celebrate the collapse of our language. “In patients with a history of MI, interruption of long-term beta-blocker trea…
RT @SeeFisch: WELL THIS WILL BE A HUGE CHANGE IN THE STANDARD OF CARE Beta-Blocker Interruption or Continuation after Myocardial Infarctio…
RT @adamcifu: Let’s celebrate the collapse of our language. “In patients with a history of MI, interruption of long-term beta-blocker trea…
RT @adamcifu: Let’s celebrate the collapse of our language. “In patients with a history of MI, interruption of long-term beta-blocker trea…
Let’s celebrate the collapse of our language. “In patients with a history of MI, interruption of long-term beta-blocker treatment was not found to be noninferior to a strategy of beta-blocker continuation.” https://t.co/Nhwfp1vGEI
RT @SeeFisch: WELL THIS WILL BE A HUGE CHANGE IN THE STANDARD OF CARE Beta-Blocker Interruption or Continuation after Myocardial Infarctio…
EFの保たれている心筋梗塞後の患者で、6ヶ月安定していた患者に対して、βブロッカーを継続群と中止群を比較したRCT βブロッカー中止は非劣性マージンは超えないが、複合イベント増える傾向にあり これだけで止めていいとはならなそう。 https://t.co/bGJOh38SPS
RT @NEJM: Original Article: Beta-Blocker Interruption or Continuation after Myocardial Infarction (ABYSS) https://t.co/UdF3kWbFsE Editor…
RT @NEJM: Original Article: Beta-Blocker Interruption or Continuation after Myocardial Infarction (ABYSS) https://t.co/UdF3kWbFsE Editor…
RT @SeeFisch: WELL THIS WILL BE A HUGE CHANGE IN THE STANDARD OF CARE Beta-Blocker Interruption or Continuation after Myocardial Infarctio…
RT @michael_hoerger: Their wording is technically accurate, and likely required within the main text of a journal article, given the nuance…
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @SeeFisch: WELL THIS WILL BE A HUGE CHANGE IN THE STANDARD OF CARE Beta-Blocker Interruption or Continuation after Myocardial Infarctio…
RT @NEJM: Original Article: Beta-Blocker Interruption or Continuation after Myocardial Infarction (ABYSS) https://t.co/UdF3kWbFsE Editor…
RT @SeeFisch: WELL THIS WILL BE A HUGE CHANGE IN THE STANDARD OF CARE Beta-Blocker Interruption or Continuation after Myocardial Infarctio…
RT @SeeFisch: WELL THIS WILL BE A HUGE CHANGE IN THE STANDARD OF CARE Beta-Blocker Interruption or Continuation after Myocardial Infarctio…
RT @SeeFisch: WELL THIS WILL BE A HUGE CHANGE IN THE STANDARD OF CARE Beta-Blocker Interruption or Continuation after Myocardial Infarctio…
RT @SeeFisch: WELL THIS WILL BE A HUGE CHANGE IN THE STANDARD OF CARE Beta-Blocker Interruption or Continuation after Myocardial Infarctio…
RT @SeeFisch: WELL THIS WILL BE A HUGE CHANGE IN THE STANDARD OF CARE Beta-Blocker Interruption or Continuation after Myocardial Infarctio…
WELL THIS WILL BE A HUGE CHANGE IN THE STANDARD OF CARE Beta-Blocker Interruption or Continuation after Myocardial Infarction | New England Journal of Medicine https://t.co/RAM9tJdHZD
RT @NEJM: Original Article: Beta-Blocker Interruption or Continuation after Myocardial Infarction (ABYSS) https://t.co/UdF3kWbFsE Editor…
RT @NEJM: Original Article: Beta-Blocker Interruption or Continuation after Myocardial Infarction (ABYSS) https://t.co/UdF3kWbFsE Editor…
RT @NEJM: Original Article: Beta-Blocker Interruption or Continuation after Myocardial Infarction (ABYSS) https://t.co/UdF3kWbFsE Editor…
RT @NEJM: Original Article: Beta-Blocker Interruption or Continuation after Myocardial Infarction (ABYSS) https://t.co/UdF3kWbFsE Editor…
RT @NEJM: Original Article: Beta-Blocker Interruption or Continuation after Myocardial Infarction (ABYSS) https://t.co/UdF3kWbFsE Editor…
RT @NEJM: Original Article: Beta-Blocker Interruption or Continuation after Myocardial Infarction (ABYSS) https://t.co/UdF3kWbFsE Editor…
RT @NEJM: Original Article: Beta-Blocker Interruption or Continuation after Myocardial Infarction (ABYSS) https://t.co/UdF3kWbFsE Editor…
Their wording is technically accurate, and likely required within the main text of a journal article, given the nuanced study design. It's just not appropriate for a plain language summary. Article: https://t.co/HpblnQFg2q "Plain language summary": https://t.co/ZwF6TOUBSI
RT @NEJM: Original Article: Beta-Blocker Interruption or Continuation after Myocardial Infarction (ABYSS) https://t.co/UdF3kWbFsE Editor…
RT @NEJM: Original Article: Beta-Blocker Interruption or Continuation after Myocardial Infarction (ABYSS) https://t.co/UdF3kWbFsE Editor…
RT @NEJM: Original Article: Beta-Blocker Interruption or Continuation after Myocardial Infarction (ABYSS) https://t.co/UdF3kWbFsE Editor…
RT @NEJM: Original Article: Beta-Blocker Interruption or Continuation after Myocardial Infarction (ABYSS) https://t.co/UdF3kWbFsE Editor…
RT @NEJM: Original Article: Beta-Blocker Interruption or Continuation after Myocardial Infarction (ABYSS) https://t.co/UdF3kWbFsE Editor…
RT @NEJM: Original Article: Beta-Blocker Interruption or Continuation after Myocardial Infarction (ABYSS) https://t.co/UdF3kWbFsE Editor…
RT @NEJM: Original Article: Beta-Blocker Interruption or Continuation after Myocardial Infarction (ABYSS) https://t.co/UdF3kWbFsE Editor…
RT @NEJM: Original Article: Beta-Blocker Interruption or Continuation after Myocardial Infarction (ABYSS) https://t.co/UdF3kWbFsE Editor…
Original Article: Beta-Blocker Interruption or Continuation after Myocardial Infarction (ABYSS) https://t.co/UdF3kWbFsE Editorial: Routine Beta-Blockers in Secondary Prevention — Approaching Retirement? https://t.co/T4PkhhP4Gx #Cardiology https://t.co/kKnrINvYDQ
Beta-Blocker Interruption or Continuation after Myocardial Infarction | New England Journal of Medicine https://t.co/ApFAofGSFt
RT @RevistaMFSamfyc: Interrupción o continuación de los beta-bloqueantes tras infarto de miocardio https://t.co/4xlf2GIVuv PMID 39213187
RT @NEJM: Original Article: Beta-Blocker Interruption or Continuation after Myocardial Infarction (ABYSS) https://t.co/UdF3kWbFsE Editori…
RT @twmu_cardiology:
Beta-Blocker Interruption or Continuation after Myocardial Infarction | New England Journal of Medicine https://t.co/VPJcpgBj9J
Interrupción o continuación de los beta-bloqueantes tras infarto de miocardio https://t.co/4xlf2GIVuv PMID 39213187
Beta-Blocker Interruption or Continuation after Myocardial Infarction | New England Journal of Medicine https://t.co/UWGjJSwE8T
RT @bryanacotton1: Don’t. Stop. The beta-blocker. 3% absolute risk difference with discontinuation (<0.05). Beta-Blocker Interruption or…
RT @EricTopol: Questioning the role of beta blockers for protecting vs cardiovascular events after a heart attack, from a randomized trial…
RT @Takatsuki_GIM: [NEJM掲載:心筋梗塞後のβ遮断薬] ABYSS試験は心筋梗塞既往に対するβ遮断薬を受けている、EF>40%、6ヶ月以内に心血管イベントがない患者を対象に、β遮断薬中断群と継続群で評価されたものです 心疾患→β遮断薬の漫然とした使用…
[NEJM掲載:心筋梗塞後のβ遮断薬] ABYSS試験は心筋梗塞既往に対するβ遮断薬を受けている、EF>40%、6ヶ月以内に心血管イベントがない患者を対象に、β遮断薬中断群と継続群で評価されたものです 心疾患→β遮断薬の漫然とした使用 ではなくなっていきそうです DOI: 10.1056/NEJMoa2404204 https://t.co/l8yVc03Hhf
Beta-Blocker Interruption or Continuation after Myocardial Infarction | New England Journal of Medicine https://t.co/nx7BtlH6As
Beta-Blocker Interruption or Continuation with Prior Myocardial Infarction
ABYSS trial: In Pts at least 6 mo post-MI (median time 2.9 yrs; 95% revascularized) without HF, EF<40%, cardiac event in past 6 mo, or indication for BB, BB interruption was not non-inferior to BB continuation at 3.0 yrs for MACE. No difference in QOL. https://t.co/UY6H3sEMe8 https://t.co/FoCnmZnBVK
En pacientes con historia de IM la interrupción del tratamiento a largo plazo con bloqueantes beta no es inferior a la continuación del tratamiento #betablocker #MI https://t.co/XuUdj47OK9
Beta-Blocker Interruption or Continuation after Myocardial Infarction In patients with a history of myocardial infarction, interruption of long-term beta-blocker treatment was not found to be noninferior to a strategy of beta-blocker continuation https://t.co/zIpxhFHc3p
こちらは8月お盆に収録していたのですが、すでに次のエビデンスも出ているというスピード感。循環器領域追いかけるのは特に大変汗 https://t.co/tgfUw01jIK https://t.co/4HUqc2reaS
Beta-Blocker Interruption or Continuation after Myocardial Infarction | New England Journal of Medicine https://t.co/ySSD5XqykF
RT @catcardiocamfic: Beta-Blocker interruption or continuation after Myocardial Infarction: interruption of long-term beta-blocker treatmen…
Beta-Blocker interruption or continuation after Myocardial Infarction: interruption of long-term beta-blocker treatment was not found to be noninferior to a strategy of beta-blocker continuation @NEJM https://t.co/rSCQw9B9Mz
https://t.co/sjdmZZE68q
https://t.co/PEYDu7GO10
Beta-Blocker Interruption or Continuation after Myocardial Infarction | New England Journal of Medicine https://t.co/ecl1JfyHp4
Don’t. Stop. The beta-blocker. 3% absolute risk difference with discontinuation (<0.05). Beta-Blocker Interruption or Continuation after Myocardial Infarction | New England Journal of Medicine https://t.co/okvpiuVFJq
Buena información en un tema de debate actual. Estos resultados respaldan mantener tratamiento con Beta-bloqueador en pacientes con infarto de miocardio. Beta-Blocker Interruption or Continuation after Myocardial Infarction New England Journal of Medicine https://t.co/6Ax0wTeHUs
RT @DrDamluji: Beta-Blocker Interruption or Continuation after Myocardial Infarction: @NEJM
RT @DrDamluji: Beta-Blocker Interruption or Continuation after Myocardial Infarction: @NEJM
RT @DrDamluji: Beta-Blocker Interruption or Continuation after Myocardial Infarction: @NEJM
Beta-Blocker Interruption or Continuation after Myocardial Infarction #science #publication #research #journal https://t.co/j0TCojuG6r
https://t.co/aBcLpB9wBD と https://t.co/h4iEaMjVFs です
RT @ernestocardio: Beta-Blocker Interruption or Continuation after Myocardial Infarction | New England Journal of Medicine https://t.co/ZGl…
RT @DrDamluji: Beta-Blocker Interruption or Continuation after Myocardial Infarction: @NEJM
RT @NEJM: Original Article: Beta-Blocker Interruption or Continuation after Myocardial Infarction (ABYSS) https://t.co/UdF3kWbFsE Editori…
RT @NEJM: Original Article: Beta-Blocker Interruption or Continuation after Myocardial Infarction (ABYSS) https://t.co/UdF3kWbFsE Editori…
RT @NEJM: Original Article: Beta-Blocker Interruption or Continuation after Myocardial Infarction (ABYSS) https://t.co/UdF3kWbFsE Editori…
RT @DrDamluji: Beta-Blocker Interruption or Continuation after Myocardial Infarction: @NEJM
RT @NEJM: Original Article: Beta-Blocker Interruption or Continuation after Myocardial Infarction (ABYSS) https://t.co/UdF3kWbFsE Editori…
RT @NEJM: Original Article: Beta-Blocker Interruption or Continuation after Myocardial Infarction (ABYSS) https://t.co/UdF3kWbFsE Editori…
RT @DrDamluji: Beta-Blocker Interruption or Continuation after Myocardial Infarction: @NEJM
RT @NEJM: Original Article: Beta-Blocker Interruption or Continuation after Myocardial Infarction (ABYSS) https://t.co/UdF3kWbFsE Editori…
RT @DrDamluji: Beta-Blocker Interruption or Continuation after Myocardial Infarction: @NEJM
Trend up+289: Silvain J, ..., Abyss Investigators of the ACTION Study Group (N Engl J Med) __Beta-Blocker Interruption or Continuation after Myocardial Infarction__ https://t.co/dQF5q9U3Zx
RT @NEJM: Original Article: Beta-Blocker Interruption or Continuation after Myocardial Infarction (ABYSS) https://t.co/UdF3kWbFsE Editori…
RT @DrDamluji: Beta-Blocker Interruption or Continuation after Myocardial Infarction: @NEJM
RT @NEJM: Original Article: Beta-Blocker Interruption or Continuation after Myocardial Infarction (ABYSS) https://t.co/UdF3kWbFsE Editori…
Beta-Blocker Interruption or Continuation after Myocardial Infarction In patients with a history of myocardial infarction, interruption of long-term beta-blocker treatment was not found to be noninferior to a strategy of beta-blocker continuation https://t.co/zIpxhFHc3p https://t.co/RVL2TRP16v
RT @NEJM: Original Article: Beta-Blocker Interruption or Continuation after Myocardial Infarction (ABYSS) https://t.co/UdF3kWbFsE Editori…
RT @ernestocardio: Beta-Blocker Interruption or Continuation after Myocardial Infarction | New England Journal of Medicine https://t.co/ZGl…
RT @ernestocardio: Beta-Blocker Interruption or Continuation after Myocardial Infarction | New England Journal of Medicine https://t.co/ZGl…
RT @DrDamluji: Beta-Blocker Interruption or Continuation after Myocardial Infarction: @NEJM
RT @DrDamluji: Beta-Blocker Interruption or Continuation after Myocardial Infarction: @NEJM
RT @DrDamluji: Beta-Blocker Interruption or Continuation after Myocardial Infarction: @NEJM
RT @DrDamluji: Beta-Blocker Interruption or Continuation after Myocardial Infarction: @NEJM
RT @DrDamluji: Beta-Blocker Interruption or Continuation after Myocardial Infarction: @NEJM
RT @NEJM: Original Article: Beta-Blocker Interruption or Continuation after Myocardial Infarction (ABYSS) https://t.co/UdF3kWbFsE Editori…
RT @DrDamluji: Beta-Blocker Interruption or Continuation after Myocardial Infarction: @NEJM
RT @NEJM: Original Article: Beta-Blocker Interruption or Continuation after Myocardial Infarction (ABYSS) https://t.co/UdF3kWbFsE Editori…
RT @DrDamluji: Beta-Blocker Interruption or Continuation after Myocardial Infarction: @NEJM
RT @DrDamluji: Beta-Blocker Interruption or Continuation after Myocardial Infarction: @NEJM
RT @DrDamluji: Beta-Blocker Interruption or Continuation after Myocardial Infarction: @NEJM
Beta-Blocker Interruption or Continuation after Myocardial Infarction https://t.co/md69ivIjMc